Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Ciena Corporation (CIEN) Sets the Stage for a Broad Networking Surge: JDS Uniphase Corp (JDSU), Finisar Corporation (FNSR)

Page 1 of 2

Ciena (CIEN)Ciena Corporation (NASDAQ:CIEN) is giving new hope to the entire high-speed networking sector today.

Shares of the optical networking equipment vendor jumped as much as 17.6% overnight thanks to this morning’s terrific earnings report. The company reported $0.12 of adjusted earnings per share, up from a $0.17 loss last year and way ahead of the $0.17 loss per share that analysts were expecting. Sales that came in 9% higher year-over-year also beat Wall Street’s targets.

The company is enjoying a surge of orders from the telecom sector, setting the stage for an industrywide rebound. North America is coming on strong as service providers shift into next-generation 4G networking at an accelerated pace, and even Europe is coming around. “We’re seeing a lot of activity and opportunities within some of the big tier ones around the globe,” said CEO Gary Smith.

That’s why the report worked wonders for Ciena’s ecosystem of rivals and component suppliers as well.

CIEN Chart

CIEN data by YCharts.

Components provider Finisar Corporation (NASDAQ:FNSR) took an 8.9% leap just ahead of its own earnings report after tonight’s closing bell. Finisar’s quarter will either confirm or debunk Ciena Corporation (NASDAQ:CIEN)’s market view. Investors are betting on the “confirm” line, and I’m inclined to agree.

Page 1 of 2

Biotech Insider Alert - $5 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!